Earnings

Severe miss driven by tariff headwinds and promotional pressure. J.Jill, Inc. delivered adjusted loss per share of -$0.02 for Q4…

BIO-key International delivered a narrower quarterly loss but revenue deterioration accelerated, raising questions about near-term growth visibility despite ...

Losses Narrow Substantially. BIO-key International, Inc. (NASDAQ:BKYI) posted a loss per share of -$0.19 for Q4 2025, representing a 58.7%…

Solid Quarter Delivered. FactSet Research Systems Inc. (NYSE:FDS) reported Q2 2026 adjusted diluted earnings of $4.46 per share on revenue…

Solid beat. McCormick & Company, Incorporated (NYSE:MKC) delivered Q1 2026 adjusted EPS of $0.66, clearing expectations as the spice and…

Significant Miss. J.Jill, Inc. (NYSE:JILL) delivered a disappointing fourth quarter, reporting an adjusted loss of $0.02 per share against Wall…

Company Overview DiaMedica Therapeutics is a clinical-stage biopharmaceutical company focused on treatments for preeclampsia, fetal growth restriction, and acute ischemic…

Company Overview VerifyMe, Inc. provides brand protection and precision logistics solutions for time- and temperature-sensitive products. Key Financial Figures The…

Company Overview Lantern Pharma is an oncology company utilizing its AI platform, RADR, to advance precision drug development. It maintains…

Company Overview Phreesia, Inc. provides digital patient activation solutions, including tools for intake, outreach, and education, to enhance the patient…